Daniel Sabanes Bove
Daniel Sabanes Bove
Geverifieerd e-mailadres voor roche.com - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Applied Statistical Inference: Likelihood and Bayes
L Held, D Sabanés Bové
Berlin, Heidelberg: Springer Berlin Heidelberg, 2014
171*2014
Hyper-g priors for generalized linear models
D Sabanés Bové, L Held
Bayesian Analysis 6 (3), 387-410, 2011
962011
Pilot study on HTR2A promoter polymorphism,− 1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive–compulsive …
S Walitza, DS Bové, M Romanos, T Renner, L Held, M Simons, ...
Journal of Neural Transmission 119 (4), 507-515, 2012
372012
Reduction of Thromboembolic Events in Meningioma Surgery: A Cohort Study of 724 Consecutive Patients
CV Eisenring, MC Neidert, DS Bové, L Held, J Sarnthein, N Krayenbühl
PLOS ONE 8 (11), e79170, 2013
322013
Sensitization to Common Ragweed in Southern Bavaria: Clinical and Geographical Risk Factors in Atopic Patients
F Ruëff, B Przybilla, A Walker, J Gmeiner, M Kramer, D Sabanés-Bové, ...
International Archives of Allergy and Immunology 159 (1), 65-74, 2012
282012
Bayesian fractional polynomials
DS Bové, L Held
Statistics and Computing 21 (3), 309-324, 2011
252011
Approximate Bayesian model selection with the deviance statistic
L Held, DS Bové, I Gravestock
Statistical Science 30 (2), 242-257, 2015
192015
Objective Bayesian Model Selection in Generalised Additive Models with Penalised Splines
DS Bové, L Held, G Kauermann
Journal of Computational and Graphical Statistics, 00-00, 2014
18*2014
Objective Bayesian model selection for Cox regression
L Held, I Gravestock, D Sabanés Bové
Statistics in Medicine 35 (29), 5376-5390, 2016
132016
Bayesian adaptive dose‐escalation designs for simultaneously estimating the optimal and maximum safe dose based on safety and efficacy
WY Yeung, B Reigner, U Beyer, C Diack, D Sabanés bové, G Palermo, ...
Pharmaceutical statistics 16 (6), 396-413, 2017
92017
Validating and updating a risk model for pneumonia–a case study
U Held, D Bové, J Steurer, L Held
BMC Medical Research Methodology 12 (1), 99, 2012
82012
Choice of generalized linear mixed models using predictive crossvalidation
J Braun, D Sabanés Bové, L Held
Computational Statistics & Data Analysis 75, 190-202, 2014
32014
Model-Based Dose Escalation Designs in R with crmPack
D Sabanés Bové, WY Yeung, G Palermo, T Jaki
Journal of Statistical Software 89 (10), 2019
22019
Comment on Cai and Betensky (2003), On the Poisson Approximation for Hazard Regression
DS Bové, L Held
Biometrics 69 (3), 795-795, 2013
22013
A model-based view on outbreak detection
L Held, M Paul, DS Bové
Conference of Statistical Methods for Outbreak Detection, 2010
12010
Predictive Assessment of Bayesian Hierarchical Models
D Sabanes Bove
Institut für Statistik, 2009
12009
Using the package crmPack: introductory examples
DS Bové, WY Yeung
2019
Early FDG-PET response correlates with dose and efficacy in patients with microsatellite stable mCRC treated with carcinoembryonic antigen T cell bispecific (CEA-TCB) antibody …
S Bouseida, F Sandoval, DS Bove, V Karanikas, A Keelara, T Nayak, ...
JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017
2017
Experiences and lessons from innovative dose escalation designs in early-phase oncology
J Zhu, U Beyer, S Sarkar, G Nichols, W Pao, DS Bové
Cancer Research 77 (13 Supplement), 3597-3597, 2017
2017
Dual-objective Bayesian adaptive dose-escalation procedures utilizing a gain function with binary and continuous responses
W Yeung, B Reigner, U Beyer, C Diack, DS Bove, G Palermo, T Jaki
2015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20